Zacks rates AmSurg stock a ‘hold’

Zacks has lowered its rating of AmSurg stock from “buy” to “hold,” according to The Legacy.

Advertisement

AmSurg stock has a 52-week low of $45.19 and a 52-week high of $72.85. AmSurg has a market cap of $3.36 billion, according to the report.

More articles on transactions and valuation issues:
Physicians file CON for new surgery center in Vermont: 4 things to know
5 things to know about Tenet’s cash flow
12 questions to ask potential “strategic” ASC corporate partners

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.